RPTX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 124933 min ago

@ $7.51

Išleistas: 13 vas. 2024 @ 16:30

Grąža: -51.53%

Ankstesnis signalas: vas. 12 - 16:40

Ankstesnis signalas: Pardavimas

Grąža: -7.28 %

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 23:00):

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States...

Stats
Šios dienos apimtis	720 631
Vidutinė apimtis	207 898
Rinkos kapitalizacija	154.50M
EPS	$0 ( 2024-02-27 )
Kita pelno data	( $-0.100 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.630
ATR14	$0.0150 (0.41%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Segal Lloyd Mitchell	Sell	2 650	Common Shares
2024-04-01	Segal Lloyd Mitchell	Sell	2 491	Common Shares
2024-03-28	Forte Steve	Sell	825	Common Shares
2024-04-01	Forte Steve	Sell	789	Common Shares
2024-03-28	Zinda Michael	Sell	450	Common Shares

INSIDER POWER
71.67
Last 99 transactions
Buy: 4 214 315 \| Sell: 3 499 776

Tūris Koreliacija

Ilgas: -0.36 (neutral)

Trumpas: 0.83 (strong)

Signal:(40.409) Same movement expected

Repare Therapeutics Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ARKO	0.945
JRJC	0.933
HAIN	0.933
FRHC	0.932
TTEC	0.929
LUNA	0.926
SIRI	0.926
SBNYP	0.922
HCDIP	0.921
NLSP	0.92

10 Labiausiai neigiamai susiję koreliacijos
VITL	-0.945
TRMR	-0.94
VTVT	-0.937
ROOT	-0.926
STAA	-0.923
AEYE	-0.922
PPC	-0.922
ENTX	-0.922
TWLVU	-0.913
DAKT	-0.913

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Repare Therapeutics Inc. Koreliacija - Valiuta/Žaliavos

0.33
( neutral )

0.64
( weak )

0.00
( neutral )

-0.27
( neutral )

-0.50
( weak negative )

0.28
( neutral )

Repare Therapeutics Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$51.13M
Bruto pelnas:	$49.18M (96.18 %)
EPS:	$-2.23

FY	2023
Pajamos:	$51.13M
Bruto pelnas:	$49.18M (96.18 %)
EPS:	$-2.23

FY	2022
Pajamos:	$131.83M
Bruto pelnas:	$127.65M (96.83 %)
EPS:	$-0.690

FY	2021
Pajamos:	$7.60M
Bruto pelnas:	$7.60M (100.00 %)
EPS:	$-2.97

Financial Reports:

No articles found.

Repare Therapeutics Inc.

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.

Realaus laiko atnaujinimai Repare Therapeutics Inc. [RPTX]

Upcoming Earnings Alert